McKesson Corporation (NYSE: MCK) Stock Competitors & Peer Comparison
See MCK's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MCK and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MCK | $853.71 | -1.79% | 99.9B | 20.91 | $40.82 | +0.38% |
| COR | $317.10 | +0.31% | 61.7B | 18.48 | $17.15 | +0.75% |
| CAH | $234.85 | -0.06% | 55B | 22.52 | $10.43 | +0.86% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $89.29 | +0.07% | 10.2B | 16.82 | $5.31 | N/A |
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +2.49% |
| PBH | $51.68 | +3.28% | 2.4B | 11.44 | $4.42 | N/A |
| OMI | $2.68 | +8.94% | 207.1M | -0.47 | -$5.69 | N/A |
| ACH | $1.32 | +17.33% | 101.1M | 1.94 | $0.68 | N/A |
| HX | $2.24 | -4.27% | 53.4M | -1.84 | -$1.22 | N/A |
Stock Comparison
Cencora, Inc. (NYSE: COR)
MCK vs COR Comparison August 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 99.9B. In comparison, COR has a market cap of 61.7B. Regarding current trading prices, MCK is priced at $853.71 on the NYSE, while COR trades at $317.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 20.91, whereas COR's P/E ratio is 18.48. In terms of profitability, MCK's ROE is -1.94%, compared to COR's ROE of +1.06%. Regarding short-term risk, MCK is less volatile compared to COR. This indicates lower risk in terms of short-term price fluctuations for MCK.Check COR's competition here
Cardinal Health, Inc. (NYSE: CAH)
MCK vs CAH Comparison August 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 99.9B. In comparison, CAH has a market cap of 55B. Regarding current trading prices, MCK is priced at $853.71 on the NYSE, while CAH trades at $234.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 20.91, whereas CAH's P/E ratio is 22.52. In terms of profitability, MCK's ROE is -1.94%, compared to CAH's ROE of -0.60%. Regarding short-term risk, MCK is less volatile compared to CAH. This indicates lower risk in terms of short-term price fluctuations for MCK.Check CAH's competition here
AmerisourceBergen Corporation (NYSE: ABC)
MCK vs ABC Comparison August 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 99.9B. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, MCK is priced at $853.71 on the NYSE, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 20.91, whereas ABC's P/E ratio is 21.92. In terms of profitability, MCK's ROE is -1.94%, compared to ABC's ROE of +1.06%. Regarding short-term risk, MCK is more volatile compared to ABC. This indicates higher risk in terms of short-term price fluctuations for MCK.Check ABC's competition here
Henry Schein, Inc. (NASDAQ: HSIC)
MCK vs HSIC Comparison August 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 99.9B. In comparison, HSIC has a market cap of 10.2B. Regarding current trading prices, MCK is priced at $853.71 on the NYSE, while HSIC trades at $89.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 20.91, whereas HSIC's P/E ratio is 16.82. In terms of profitability, MCK's ROE is -1.94%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, MCK is less volatile compared to HSIC. This indicates lower risk in terms of short-term price fluctuations for MCK.Check HSIC's competition here
Patterson Companies, Inc. (NASDAQ: PDCO)
MCK vs PDCO Comparison August 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 99.9B. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, MCK is priced at $853.71 on the NYSE, while PDCO trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 20.91, whereas PDCO's P/E ratio is 20.48. In terms of profitability, MCK's ROE is -1.94%, compared to PDCO's ROE of +0.18%. Regarding short-term risk, MCK is more volatile compared to PDCO. This indicates higher risk in terms of short-term price fluctuations for MCK.Check PDCO's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
MCK vs PBH Comparison August 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 99.9B. In comparison, PBH has a market cap of 2.4B. Regarding current trading prices, MCK is priced at $853.71 on the NYSE, while PBH trades at $51.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 20.91, whereas PBH's P/E ratio is 11.44. In terms of profitability, MCK's ROE is -1.94%, compared to PBH's ROE of +0.09%. Regarding short-term risk, MCK is less volatile compared to PBH. This indicates lower risk in terms of short-term price fluctuations for MCK.Check PBH's competition here
Owens & Minor, Inc. (NYSE: OMI)
MCK vs OMI Comparison August 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 99.9B. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, MCK is priced at $853.71 on the NYSE, while OMI trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 20.91, whereas OMI's P/E ratio is -0.47. In terms of profitability, MCK's ROE is -1.94%, compared to OMI's ROE of +0.63%. Regarding short-term risk, MCK is less volatile compared to OMI. This indicates lower risk in terms of short-term price fluctuations for MCK.Check OMI's competition here
Accendra Health, Inc. (NYSE: ACH)
MCK vs ACH Comparison August 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 99.9B. In comparison, ACH has a market cap of 101.1M. Regarding current trading prices, MCK is priced at $853.71 on the NYSE, while ACH trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 20.91, whereas ACH's P/E ratio is 1.94. In terms of profitability, MCK's ROE is -1.94%, compared to ACH's ROE of +0.63%. Regarding short-term risk, MCK is less volatile compared to ACH. This indicates lower risk in terms of short-term price fluctuations for MCK.Check ACH's competition here
Akso Health Group (NASDAQ: HX)
MCK vs HX Comparison August 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 99.9B. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, MCK is priced at $853.71 on the NYSE, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 20.91, whereas HX's P/E ratio is -1.84. In terms of profitability, MCK's ROE is -1.94%, compared to HX's ROE of -1.07%. Regarding short-term risk, MCK is less volatile compared to HX. This indicates lower risk in terms of short-term price fluctuations for MCK.Check HX's competition here
111, Inc. (NASDAQ: YI)
MCK vs YI Comparison August 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 99.9B. In comparison, YI has a market cap of 31.9M. Regarding current trading prices, MCK is priced at $853.71 on the NYSE, while YI trades at $3.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 20.91, whereas YI's P/E ratio is -2.61. In terms of profitability, MCK's ROE is -1.94%, compared to YI's ROE of +0.14%. Regarding short-term risk, MCK is more volatile compared to YI. This indicates higher risk in terms of short-term price fluctuations for MCK.Check YI's competition here
Wellgistics Health, Inc. (NASDAQ: WGRX)
MCK vs WGRX Comparison August 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 99.9B. In comparison, WGRX has a market cap of 8.7M. Regarding current trading prices, MCK is priced at $853.71 on the NYSE, while WGRX trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 20.91, whereas WGRX's P/E ratio is -0.33. In terms of profitability, MCK's ROE is -1.94%, compared to WGRX's ROE of +8.78%. Regarding short-term risk, MCK is less volatile compared to WGRX. This indicates lower risk in terms of short-term price fluctuations for MCK.Check WGRX's competition here
Zynex, Inc. (NASDAQ: ZYXI)
MCK vs ZYXI Comparison August 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 99.9B. In comparison, ZYXI has a market cap of 3.8M. Regarding current trading prices, MCK is priced at $853.71 on the NYSE, while ZYXI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 20.91, whereas ZYXI's P/E ratio is -0.05. In terms of profitability, MCK's ROE is -1.94%, compared to ZYXI's ROE of +11.38%. Regarding short-term risk, MCK is more volatile compared to ZYXI. This indicates higher risk in terms of short-term price fluctuations for MCK.Check ZYXI's competition here
DataMEDS AI, Inc. (NASDAQ: MEDS)
MCK vs MEDS Comparison August 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 99.9B. In comparison, MEDS has a market cap of 3.8M. Regarding current trading prices, MCK is priced at $853.71 on the NYSE, while MEDS trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 20.91, whereas MEDS's P/E ratio is N/A. In terms of profitability, MCK's ROE is -1.94%, compared to MEDS's ROE of +8.78%. Regarding short-term risk, MCK is less volatile compared to MEDS. This indicates lower risk in terms of short-term price fluctuations for MCK.Check MEDS's competition here
ZeroStack Corp. (NASDAQ: ZSTK)
MCK vs ZSTK Comparison August 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 99.9B. In comparison, ZSTK has a market cap of 2.5M. Regarding current trading prices, MCK is priced at $853.71 on the NYSE, while ZSTK trades at $2.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 20.91, whereas ZSTK's P/E ratio is -0.05. In terms of profitability, MCK's ROE is -1.94%, compared to ZSTK's ROE of -3.82%. Regarding short-term risk, MCK is less volatile compared to ZSTK. This indicates lower risk in terms of short-term price fluctuations for MCK.Check ZSTK's competition here
Synergy CHC Corp. (NASDAQ: SNYR)
MCK vs SNYR Comparison August 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 99.9B. In comparison, SNYR has a market cap of 1.1M. Regarding current trading prices, MCK is priced at $853.71 on the NYSE, while SNYR trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 20.91, whereas SNYR's P/E ratio is -0.08. In terms of profitability, MCK's ROE is -1.94%, compared to SNYR's ROE of +0.91%. Regarding short-term risk, MCK is less volatile compared to SNYR. This indicates lower risk in terms of short-term price fluctuations for MCK.Check SNYR's competition here
Ridgetech, Inc. (NASDAQ: RDGT)
MCK vs RDGT Comparison August 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 99.9B. In comparison, RDGT has a market cap of 729.3K. Regarding current trading prices, MCK is priced at $853.71 on the NYSE, while RDGT trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 20.91, whereas RDGT's P/E ratio is -0.01. In terms of profitability, MCK's ROE is -1.94%, compared to RDGT's ROE of -0.04%. Regarding short-term risk, MCK is less volatile compared to RDGT. This indicates lower risk in terms of short-term price fluctuations for MCK.Check RDGT's competition here
Covetrus, Inc. (NASDAQ: CVET)
MCK vs CVET Comparison August 2026
McKesson Corporation (NYSE: MCK) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MCK stands at 99.9B. In comparison, CVET has a market cap of 0. Regarding current trading prices, MCK is priced at $853.71 on the NYSE, while CVET trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MCK currently has a P/E ratio of 20.91, whereas CVET's P/E ratio is -69.97. In terms of profitability, MCK's ROE is -1.94%, compared to CVET's ROE of -0.06%. Regarding short-term risk, MCK is more volatile compared to CVET. This indicates higher risk in terms of short-term price fluctuations for MCK.Check CVET's competition here